Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT04587453 · COMPLETED
Trial details
- NCT number
- NCT04587453
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2021-07-06
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.